JENNIFER KEITH: Open Payments
NPI 1275015901 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,705 in 60 payments from 20 companies in 2025. Trend: 2023 $1,358 · 2024 $1,842 · 2025 $1,705
Food & beverage: $1,345Education: $360
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $293 |
| Janssen Biotech, Inc. | 5 | $289 |
| Endo USA, Inc. | 9 | $221 |
| ACCORD HEALTHCARE, INC. | 8 | $182 |
| Sumitomo Pharma America, Inc. | 5 | $109 |
| SEAGEN INC. | 1 | $85 |
| TOLMAR, INC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| PFIZER INC. | 3 | $61 |
| Medtronic, Inc. | 3 | $61 |
Products named: AVEED, Camcevi, ERLEADA, RYBREVANT, GEMTESA, XTANDI, JATENZO, Nubeqa.
Industry payments across IN — which companies pay providers there.
